Sigma Receptor Agonists: Receptor Binding and Effects on Mesolimbic Dopamine Neurotransmission Assessed by Microdialysis
- 1 February 2011
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 69 (3) , 208-217
Abstract
No abstract availableKeywords
Funding Information
- Intramural Research Program of the National Institute on Drug Abuse
- National Institutes of Health, Department of Health and Human Services
- NIDA (DA023205)
This publication has 51 references indexed in Scilit:
- Reinforcing Effects of σ-Receptor Agonists in Rats Trained to Self-Administer CocaineThe Journal of Pharmacology and Experimental Therapeutics, 2010
- The pharmacology of sigma-1 receptorsPharmacology & Therapeutics, 2009
- Targeting sigma receptors: novel medication development for drug abuse and addictionExpert Review of Clinical Pharmacology, 2009
- Effects of 4′-Chloro-3α-(diphenylmethoxy)-tropane on Mesostriatal, Mesocortical, and Mesolimbic Dopamine Transmission: Comparison with Effects of CocaineThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Behavioral Pharmacology of σ-LigandsPharmacopsychiatry, 2004
- Biphasic effect of sigma receptor ligands on the extracellular concentration of dopamine in the striatum of the ratJournal of Neural Transmission, 1999
- The attenuation of learning impairments induced after exposure to CO or trimethyltin in mice by sigma (σ) receptor ligands involves both σ1 and σ2 sitesBritish Journal of Pharmacology, 1999
- A dopamine‐μ1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non‐psychostimulant drugs of abuseEuropean Journal of Neuroscience, 1998
- Estimation of in-vivo neurotransmitter release by brain microdialysisBehavioural Pharmacology, 1996
- Rat liver and kidney contain high densities of σ1 and σ2 receptors: characterization by ligand binding and photoaffinity labelingEuropean Journal of Pharmacology: Molecular Pharmacology, 1994